or Try an Advanced Search...

    Phosphoinositide 3 Kinase Inhibitor Stocks List

    Symbol Grade Name % Change
    CRIS B Curis, Inc. 0.19
    PRLD D Prelude Therapeutics Incorporated -3.39
    APTO F Aptose Biosciences, Inc. 1.65
    APLM F Apollomics Inc. -4.14
    View As Page of Charts
    Related Industries: Biotechnology
    Related Stock Lists: Cancer Biopharmaceutical Solid Tumors Acute Myeloid Leukemia Clinical Medicine Drugs Lymphoma Medicine Non Small Cell Lung Cancer Oncology Protein Kinase Inhibitor Small Molecule Therapies Targeted Therapy Advanced Non Small Cell Lung Cancer Antineoplastic Drugs Bacterial Infections Bemcentinib Blastoma Breast Cancer Cancer Cell

    Related ETFs - A few ETFs which own one or more of the above listed Phosphoinositide 3 Kinase Inhibitor stocks.

    Symbol Grade Name Weight
    CNCR D Loncar Cancer Immunotherapy ETF 1.09
    IWC C iShares Microcap ETF 0.01
    IWM C iShares Russell 2000 ETF 0.0
    SCHB B Schwab U.S. Broad Market ETF 0.0
    HDG A ProShares Hedge Replication ETF 0.0
    View all Phosphoinositide 3 Kinase Inhibitor ETFs...
    Compare ETFs
    Compare CNCR to SCHB Compare IWC to IWM Compare IWM to HDG

        Phosphoinositide 3 Kinase Inhibitor Stocks Recent News

        Date Stock Title
        May 7 CRIS Curis GAAP EPS of -$2.05, revenue of $2.1M
        May 7 CRIS Curis Provides First Quarter 2024 Business Update
        May 7 PRLD Prelude Therapeutics GAAP EPS of -$0.42
        May 7 PRLD Prelude Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
        May 6 APTO Aptose to Report First Quarter 2024 Financial Results and Provide Clinical Strategy Update on Tuesday, May 14, 2024
        May 6 CRIS Curis Q1 2024 Earnings Preview
        Related Industries: Biotechnology
        Related Stock Lists: Cancer Biopharmaceutical Solid Tumors Acute Myeloid Leukemia Clinical Medicine Drugs Lymphoma Medicine Non Small Cell Lung Cancer Oncology Protein Kinase Inhibitor Small Molecule Therapies Targeted Therapy Advanced Non Small Cell Lung Cancer Antineoplastic Drugs Bacterial Infections Bemcentinib Blastoma Breast Cancer Cancer Cell
        Phosphoinositide 3 Kinase Inhibitor

        Phosphoinositide 3-kinase (PI3K) inhibitors are drugs that block the activity of the PI3K enzyme, which is involved in many cellular processes, including cell growth, proliferation, and survival. PI3K inhibitors are used to treat certain types of cancer, as they can help to slow or stop the growth of cancer cells.

        Browse All Tags